| NDC Code | 49281-719-10 |
|---|
| Package Description | 10 SYRINGE in 1 CARTON (49281-719-10) > .5 mL in 1 SYRINGE (49281-719-88) |
|---|
| Product NDC | 49281-719 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flublok Quadrivalent |
|---|
| Non-Proprietary Name | Influenza A Virus A/brisbane/02/2018 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/kansas/14/2017 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/maryland/15/2016 Recombinant Hemagglutinin Antigen |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20190701 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125285 |
|---|
| Manufacturer | Sanofi Pasteur Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN |
|---|
| Strength | 45; 45; 45; 45 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|